EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Wnt/β‐catenin pathway as a link between therapy resistance‐driven epithelial‐mesenchymal transition and stemness in colorectal cancer

Murilo Ramos Rocha, Yuri Kelly Castillo-Medina, Bárbara Martins de Lima Coelho, Luidy Lucas Lopes Rios, Jose Andres Morgado-Diaz

Cell Biology International · 2025

DOI: 10.1002/cbin.12270 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology International, 2025. Verfasst von Murilo Ramos Rocha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Oncobiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Colorectal Neoplasms, Wnt Signaling Pathway, Neoplastic Stem Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high plasticity of cells undergoing epithelial‐mesenchymal transition (EMT) promotes increased tumor heterogeneity, and its interaction with tumor‐associated stromal cells appears to contribute to developing a stemness phenotype. Cells with these characteristics exhibit increased resistance to chemotherapy and radiotherapy, leading to disease relapse and metastasis. Here, we discuss the activation of the Wnt/β‐catenin pathway in promoting EMT and stemness within the context of cellular resistance to these therapies. We discuss whether EMT and cancer stem cells (CSCs) function in conjunction, independently, or if a link is connecting their development. We further propose that this pathway is necessary to establish a connection between these two phenotypes. And suggest that it could hinder the rise of CSCs from treatment‐induced EMT cells when inhibited. Understanding this cellular phenomenon might allow the development of new targeted therapies to improve clinical responses, particularly in colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionColorectal NeoplasmsWnt Signaling PathwayNeoplastic Stem CellsDrug Resistance, NeoplasmHumansbeta CateninAnimals

Stichwörter der Autor:innen

Wnt/β‐catenin pathwayepithelial‐mesenchymal transitionstemnesstherapy resistance

Substanzen

beta Catenin

Autor:innen und Institutionen

  • Cellular and Molecular Oncobiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Rocha, M. R., Castillo-Medina, Y. K., de Lima Coelho, B. M., Rios, L. L. L., & Morgado-Diaz, J. A. (2025). Wnt/β‐catenin pathway as a link between therapy resistance‐driven epithelial‐mesenchymal transition and stemness in colorectal cancer. Cell Biology International. https://doi.org/10.1002/cbin.12270

Vancouver

Rocha MR, Castillo-Medina YK, de Lima Coelho BM, Rios LLL, Morgado-Diaz JA. Wnt/β‐catenin pathway as a link between therapy resistance‐driven epithelial‐mesenchymal transition and stemness in colorectal cancer. Cell Biology International. 2025. doi:10.1002/cbin.12270

BibTeX
@article{Rocha2025,
  author = {Rocha, Murilo Ramos and Castillo-Medina, Yuri Kelly and de Lima Coelho, Bárbara Martins and Rios, Luidy Lucas Lopes and Morgado-Diaz, Jose Andres},
  title = {Wnt/β‐catenin pathway as a link between therapy resistance‐driven epithelial‐mesenchymal transition and stemness in colorectal cancer},
  journal = {Cell Biology International},
  year = {2025},
  doi = {10.1002/cbin.12270}
}
Kostenlos starten →